• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

审查最终发放药物作为数据质量的一项衡量指标:韩国癌症中央登记处死亡数据的比较分析。

Examining Final-Administered Medication as a Measure of Data Quality: A Comparative Analysis of Death Data with the Central Cancer Registry in Republic of Korea.

作者信息

Tak Yae Won, Han Jeong Hyun, Park Yu Jin, Kim Do-Hoon, Oh Ji Seon, Lee Yura

机构信息

Department of Information Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.

Medical Information-Management Team, Asan Medical Center, Seoul 05505, Republic of Korea.

出版信息

Cancers (Basel). 2023 Jun 27;15(13):3371. doi: 10.3390/cancers15133371.

DOI:10.3390/cancers15133371
PMID:37444480
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10341326/
Abstract

Death is a crucial outcome in retrospective cohort studies, serving as a criterion for analyzing mortality in a database. This study aimed to assess the quality of extracted death data and investigate the potential of the final-administered medication as a variable to quantify accuracy for the validation dataset. Electronic health records from both an in-hospital and the Korean Central Cancer Registry were used for this study. The gold standard was established by examining the differences between the dates of in-hospital deaths and cancer-registered deaths. Cosine similarity was employed to quantify the final-administered medication similarities between the gold standard and other cohorts. The gold standard was determined as patients who died in the hospital after 2006 and whose final hospital visit/discharge date and death date differed by 0 or 1 day. For all three criteria-(a) cancer stage, (b) cancer type, and (c) type of final visit-there was a positive correlation between mortality rates and the similarities of the final-administered medication. This study introduces a measure that can provide additional accurate information regarding death and differentiates the reliability of the dataset.

摘要

死亡是回顾性队列研究中的一个关键结果,作为分析数据库中死亡率的一个标准。本研究旨在评估提取的死亡数据质量,并调查最终使用药物作为验证数据集准确性量化变量的潜力。本研究使用了来自一家医院和韩国中央癌症登记处的电子健康记录。通过检查住院死亡日期和癌症登记死亡日期之间的差异来建立金标准。采用余弦相似度来量化金标准与其他队列之间最终使用药物的相似性。金标准被确定为2006年后在医院死亡且最后一次住院就诊/出院日期与死亡日期相差0或1天的患者。对于所有三个标准——(a)癌症分期、(b)癌症类型和(c)最后一次就诊类型——死亡率与最终使用药物的相似性之间存在正相关。本研究引入了一种可以提供关于死亡的额外准确信息并区分数据集可靠性的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97aa/10341326/22af096d589c/cancers-15-03371-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97aa/10341326/31272ea50500/cancers-15-03371-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97aa/10341326/07ada5be6e48/cancers-15-03371-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97aa/10341326/13ec1a2c645b/cancers-15-03371-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97aa/10341326/6daf6875a99b/cancers-15-03371-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97aa/10341326/ba020e6d70d3/cancers-15-03371-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97aa/10341326/22af096d589c/cancers-15-03371-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97aa/10341326/31272ea50500/cancers-15-03371-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97aa/10341326/07ada5be6e48/cancers-15-03371-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97aa/10341326/13ec1a2c645b/cancers-15-03371-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97aa/10341326/6daf6875a99b/cancers-15-03371-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97aa/10341326/ba020e6d70d3/cancers-15-03371-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97aa/10341326/22af096d589c/cancers-15-03371-g006.jpg

相似文献

1
Examining Final-Administered Medication as a Measure of Data Quality: A Comparative Analysis of Death Data with the Central Cancer Registry in Republic of Korea.审查最终发放药物作为数据质量的一项衡量指标:韩国癌症中央登记处死亡数据的比较分析。
Cancers (Basel). 2023 Jun 27;15(13):3371. doi: 10.3390/cancers15133371.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性(COVA 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.
4
The measurement and monitoring of surgical adverse events.手术不良事件的测量与监测
Health Technol Assess. 2001;5(22):1-194. doi: 10.3310/hta5220.
5
Association between pacifier use and breast-feeding, sudden infant death syndrome, infection and dental malocclusion.安抚奶嘴使用与母乳喂养、婴儿猝死综合征、感染及牙列不齐之间的关联。
JBI Libr Syst Rev. 2005;3(6):1-33. doi: 10.11124/01938924-200503060-00001.
6
Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.伴有确诊的 2019 冠状病毒病(COVID-19)感染住院患者肾素-血管紧张素-醛固酮系统阻滞剂管理(麦吉尔 RAAS-COVID-19):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Feb 5;22(1):115. doi: 10.1186/s13063-021-05080-4.
7
Monitoring and evaluating surgical care: defining perioperative mortality rate and standardising data collection.监测和评估外科护理:定义围手术期死亡率并标准化数据收集。
Lancet. 2015 Apr 27;385 Suppl 2:S27. doi: 10.1016/S0140-6736(15)60822-4. Epub 2015 Apr 26.
8
Increasing Trend in Hospital Deaths Consistent among Older Decedents in Korea: A Population-based Study Using Death Registration Database, 2001-2014.韩国老年死者的医院死亡人数呈上升趋势:基于死亡登记数据库的 2001-2014 年的人口研究。
BMC Palliat Care. 2018 Jan 11;17(1):16. doi: 10.1186/s12904-017-0269-x.
9
[State of health of populations residing in geothermal areas of Tuscany].[托斯卡纳地热区居民的健康状况]
Epidemiol Prev. 2012 Sep-Oct;36(5 Suppl 1):1-104.
10
Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.预防性卵巢切除术:降低美国上皮性卵巢癌死亡率。一场持续的争论。
Oncologist. 1996;1(5):326-330.

引用本文的文献

1
Challenges for Data Quality in the Clinical Data Life Cycle: Systematic Review.临床数据生命周期中数据质量面临的挑战:系统评价
J Med Internet Res. 2025 Apr 23;27:e60709. doi: 10.2196/60709.

本文引用的文献

1
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2020.韩国癌症统计数据:2020 年发病率、死亡率、生存率和患病率。
Cancer Res Treat. 2023 Apr;55(2):385-399. doi: 10.4143/crt.2023.447.
2
Coding quality of deaths and its impact on elderly unintentional fall mortality data from 1990 to 2019: a retrospective analysis of the WHO Mortality Database.1990 年至 2019 年死亡编码质量及其对老年人意外跌倒死亡率数据的影响:世卫组织死亡率数据库的回顾性分析。
BMC Geriatr. 2022 Jan 24;22(1):72. doi: 10.1186/s12877-021-02744-3.
3
Public health utility of cause of death data: applying empirical algorithms to improve data quality.
死因数据的公共卫生效用:应用经验算法改善数据质量。
BMC Med Inform Decis Mak. 2021 Jun 2;21(1):175. doi: 10.1186/s12911-021-01501-1.
4
Hospital at home: home-based end-of-life care.居家医院:基于家庭的临终关怀。
Cochrane Database Syst Rev. 2021 Mar 16;3(3):CD009231. doi: 10.1002/14651858.CD009231.pub3.
5
Assessing the quality of cause of death data in six high-income countries: Australia, Canada, Denmark, Germany, Japan and Switzerland.评估六个高收入国家(澳大利亚、加拿大、丹麦、德国、日本和瑞士)的死因数据质量。
Int J Public Health. 2020 Jan;65(1):17-28. doi: 10.1007/s00038-019-01325-x. Epub 2020 Jan 14.
6
Assessment of the quality of cause-of-death data in Greenland, 2006-2015.2006-2015 年格陵兰死因数据质量评估。
Scand J Public Health. 2020 Dec;48(8):801-808. doi: 10.1177/1403494819890990. Epub 2019 Dec 19.
7
Data Entry Automation Improves Cost, Quality, Performance, and Job Satisfaction in a Hospital Nursing Unit.数据录入自动化可提高医院护理单元的成本、质量、绩效和工作满意度。
J Nurs Adm. 2020 Jan;50(1):34-39. doi: 10.1097/NNA.0000000000000836.
8
Elements of Palliative Care in the Last 6 Months of Life: Frequency, Predictors, and Timing.生命终末期 6 个月中的姑息治疗要素:频率、预测因素和时机。
J Gen Intern Med. 2020 Mar;35(3):753-761. doi: 10.1007/s11606-019-05349-0. Epub 2019 Oct 24.
9
Identifying the DEAD: Development and Validation of a Patient-Level Model to Predict Death Status in Population-Level Claims Data.识别死亡患者:基于人群水平理赔数据建立预测患者死亡状态的个体水平预测模型的开发和验证。
Drug Saf. 2019 Nov;42(11):1377-1386. doi: 10.1007/s40264-019-00827-0.
10
How to come to terms with facing death: a qualitative study examining the experiences of patients with terminal Cancer.如何接受面对死亡:一项定性研究,探讨终末期癌症患者的体验。
BMC Palliat Care. 2019 Apr 4;18(1):33. doi: 10.1186/s12904-019-0417-6.